https://www.news-medical.net/news/20230908/Senolytic-therapy-in-mild-Alzheimere28099s-disease-shows-safety-in-phase-I-trial.aspx
0
0
9/8/23 at 2:34pm
Organization
News-Medical.Net
43 words
0
Comments
Researchers conducted the phase 1 trial of orally-administered senolytic therapy comprising quercetin (Q) and dasatinib (D) for symptomatic and early-stage Alzheimer's disease (AD) patients.
You are the first to view
Create an account
or login to join the discussion